Regulated AI Advantage Ketryx offers an AI-native continuous compliance platform tailored for regulated product teams, presenting a strong cross-sell opportunity to healthcare device manufacturers seeking automated documentation, traceability, and accelerated release cycles.

Top Tier Credibility With four of the world’s top five medical device manufacturers as customers and a board including former Medtronic leadership, leverage this credibility to engage aspiring enterprise buyers in the life sciences sector.

Revenue Momentum Recent funding and growth signals, including a Series B of 39 million euros and revenue around 50 to 100 million dollars, indicate a scalable platform with expanding enterprise adoption suitable for upsell to larger dev teams.

Expansion via AWS Availability on AWS Marketplace and a tech stack aligned with common enterprise tooling (Grafana, Docker, Jenkins, Azure DevOps) create low-friction procurement and integration paths for potential customers using similar ecosystems.

Industry Events Participation in industry conferences like Validated AI Conference and ongoing investor activity signal opportunities to coordinate targeted outreach, partnerships, and executive-level conversations with decision-makers in regulated software and medical device workflows.